$TKNO
Alpha Teknova, Inc.

2024 Q4 Form 10-Q Financial Statement

#000095017024124159 Filed on November 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $9.576M
YoY Change 17.22%
Cost Of Revenue $9.486M
YoY Change 41.65%
Gross Profit $90.00K
YoY Change -93.89%
Gross Profit Margin 0.94%
Selling, General & Admin $6.608M
YoY Change -22.71%
% of Gross Profit 7342.22%
Research & Development $627.0K
YoY Change -55.12%
% of Gross Profit 696.67%
Depreciation & Amortization $1.400M
YoY Change 7.69%
% of Gross Profit 1555.56%
Operating Expenses $7.522M
YoY Change -26.5%
Operating Profit -$7.432M
YoY Change -15.18%
Interest Expense -$141.0K
YoY Change -82.15%
% of Operating Profit
Other Income/Expense, Net -$141.0K
YoY Change -89.8%
Pretax Income -$7.573M
YoY Change -25.35%
Income Tax -$8.000K
% Of Pretax Income
Net Earnings -$7.565M
YoY Change -25.49%
Net Earnings / Revenue -79.0%
Basic Earnings Per Share -$0.15
Diluted Earnings Per Share -$0.15
COMMON SHARES
Basic Shares Outstanding 53.31M 53.30M
Diluted Shares Outstanding 51.82M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $31.69M
YoY Change -1.27%
Cash & Equivalents $6.145M
Short-Term Investments $25.55M
Other Short-Term Assets $1.960M
YoY Change -18.33%
Inventory $7.674M
Prepaid Expenses
Receivables $4.605M
Other Receivables $0.00
Total Short-Term Assets $45.93M
YoY Change -10.08%
LONG-TERM ASSETS
Property, Plant & Equipment $46.72M
YoY Change -9.43%
Goodwill
YoY Change
Intangibles $13.38M
YoY Change -19.87%
Long-Term Investments
YoY Change
Other Assets $1.518M
YoY Change -22.23%
Total Long-Term Assets $78.17M
YoY Change -10.47%
TOTAL ASSETS
Total Short-Term Assets $45.93M
Total Long-Term Assets $78.17M
Total Assets $124.1M
YoY Change -10.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $975.0K
YoY Change -31.43%
Accrued Expenses $4.373M
YoY Change -15.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $2.528M
YoY Change
Total Short-Term Liabilities $9.719M
YoY Change 16.55%
LONG-TERM LIABILITIES
Long-Term Debt $10.86M
YoY Change -17.55%
Other Long-Term Liabilities $15.39M
YoY Change -3.83%
Total Long-Term Liabilities $10.86M
YoY Change -17.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.719M
Total Long-Term Liabilities $10.86M
Total Liabilities $36.83M
YoY Change -4.91%
SHAREHOLDERS EQUITY
Retained Earnings -$112.8M
YoY Change 39.1%
Common Stock $1.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $87.27M
YoY Change
Total Liabilities & Shareholders Equity $124.1M
YoY Change -10.32%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$7.565M
YoY Change -25.49%
Depreciation, Depletion And Amortization $1.400M
YoY Change 7.69%
Cash From Operating Activities -$2.059M
YoY Change -52.99%
INVESTING ACTIVITIES
Capital Expenditures $331.0K
YoY Change -65.88%
Acquisitions
YoY Change
Other Investing Activities -$25.43M
YoY Change
Cash From Investing Activities -$25.76M
YoY Change 2555.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 15.37M
YoY Change 12.74%
NET CHANGE
Cash From Operating Activities -2.059M
Cash From Investing Activities -25.76M
Cash From Financing Activities 15.37M
Net Change In Cash -12.45M
YoY Change -250.37%
FREE CASH FLOW
Cash From Operating Activities -$2.059M
Capital Expenditures $331.0K
Free Cash Flow -$2.390M
YoY Change -55.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28810068
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.91
CY2023Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
300000
CY2024Q2 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
400000
CY2024Q2 tkno Contingent Liability Of Acrual Increment
ContingentLiabilityOfAcrualIncrement
100000
CY2024Q3 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
400000
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001850902
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40538
dei Entity Registrant Name
EntityRegistrantName
ALPHA TEKNOVA, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3368109
dei Entity Address Address Line1
EntityAddressAddressLine1
2451 Bert Dr.
dei Entity Address City Or Town
EntityAddressCityOrTown
Hollister
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95023
dei City Area Code
CityAreaCode
831
dei Local Phone Number
LocalPhoneNumber
637-1100
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
TKNO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
53307689
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9576000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8169000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28480000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28817000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9486000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6697000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
23377000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19856000
CY2024Q3 us-gaap Gross Profit
GrossProfit
90000
CY2023Q3 us-gaap Gross Profit
GrossProfit
1472000
us-gaap Gross Profit
GrossProfit
5103000
us-gaap Gross Profit
GrossProfit
8961000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
627000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1397000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2165000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4256000
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1640000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2412000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4763000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6929000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4968000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6138000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17832000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19426000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
287000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
287000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
861000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
860000
CY2024Q3 tkno Impairment Of Long Lived Assets
ImpairmentOfLongLivedAssets
0
CY2023Q3 tkno Impairment Of Long Lived Assets
ImpairmentOfLongLivedAssets
0
tkno Impairment Of Long Lived Assets
ImpairmentOfLongLivedAssets
0
tkno Impairment Of Long Lived Assets
ImpairmentOfLongLivedAssets
2195000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
7522000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
10234000
us-gaap Operating Expenses
OperatingExpenses
25621000
us-gaap Operating Expenses
OperatingExpenses
33666000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7432000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8762000
us-gaap Operating Income Loss
OperatingIncomeLoss
-20518000
us-gaap Operating Income Loss
OperatingIncomeLoss
-24705000
CY2024Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-141000
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-791000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-558000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1006000
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-824000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-824000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
233000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
417000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-141000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1382000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-558000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1413000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7573000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10144000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21076000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26118000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-50000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-7565000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10153000
us-gaap Net Income Loss
NetIncomeLoss
-21026000
us-gaap Net Income Loss
NetIncomeLoss
-26124000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.91
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51821395
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51821395
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29956930
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29956930
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44520132
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44520132
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28810068
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28810068
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6145000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28484000
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
25546000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
0
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
74000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
20000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4605000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3948000
CY2024Q3 us-gaap Inventory Net
InventoryNet
7674000
CY2023Q4 us-gaap Inventory Net
InventoryNet
11594000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1960000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1634000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
45930000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
45660000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46715000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50364000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16558000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16472000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13378000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14239000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1518000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1852000
CY2024Q3 us-gaap Assets
Assets
124099000
CY2023Q4 us-gaap Assets
Assets
128587000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
975000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1493000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4373000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5579000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1843000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1803000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2528000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
9719000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8875000
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
867000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
919000
CY2024Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
30000
CY2023Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
102000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10857000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
13251000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15358000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15404000
CY2024Q3 us-gaap Liabilities
Liabilities
36831000
CY2023Q4 us-gaap Liabilities
Liabilities
38551000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
490000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
490000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53302993
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53302993
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40793848
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40793848
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
0
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
200079000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
181822000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-112812000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-91786000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
87268000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
90036000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
124099000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
128587000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
78928000
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15141000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
760000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-7565000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
87268000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
86208000
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
22562000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1035000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10153000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
99652000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
90036000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15141000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
132000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2900000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
81000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000
us-gaap Net Income Loss
NetIncomeLoss
-21026000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
87268000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
99885000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
22562000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3115000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
138000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
76000
us-gaap Net Income Loss
NetIncomeLoss
-26124000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
99652000
us-gaap Net Income Loss
NetIncomeLoss
-21026000
us-gaap Net Income Loss
NetIncomeLoss
-26124000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
61000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
21000
us-gaap Inventory Write Down
InventoryWriteDown
4235000
us-gaap Inventory Write Down
InventoryWriteDown
130000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4933000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4049000
us-gaap Share Based Compensation
ShareBasedCompensation
2900000
us-gaap Share Based Compensation
ShareBasedCompensation
3115000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-52000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
5000
tkno Accrued Interest Income On Short Term Investments
AccruedInterestIncomeOnShortTermInvestments
-118000
tkno Accrued Interest Income On Short Term Investments
AccruedInterestIncomeOnShortTermInvestments
0
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
291000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
415000
tkno Non Cash Lease Expense
NonCashLeaseExpense
140000
tkno Non Cash Lease Expense
NonCashLeaseExpense
86000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-49000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-5000
tkno Impairment Of Long Lived Assets
ImpairmentOfLongLivedAssets
0
tkno Impairment Of Long Lived Assets
ImpairmentOfLongLivedAssets
2195000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-824000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
718000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
721000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
315000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-649000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
0
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-22000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
943000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
694000
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-334000
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-300000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-430000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-948000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-724000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
815000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-72000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-66000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11455000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15922000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
25428000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
125000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
558000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7622000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25861000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7622000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15104000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22915000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
10000000
tkno Proceeds From Financed Insurance Premium
ProceedsFromFinancedInsurancePremium
385000
tkno Proceeds From Financed Insurance Premium
ProceedsFromFinancedInsurancePremium
1004000
tkno Repayment Of Financed Insurance Premiums
RepaymentOfFinancedInsurancePremiums
572000
tkno Repayment Of Financed Insurance Premiums
RepaymentOfFinancedInsurancePremiums
294000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
25000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
24000
tkno Payment Of At The Market Facility Costs
PaymentOfAtTheMarketFacilityCosts
0
tkno Payment Of At The Market Facility Costs
PaymentOfAtTheMarketFacilityCosts
395000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
76000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
81000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
138000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14977000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13420000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-22339000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10124000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28484000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42236000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6145000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32112000
us-gaap Income Taxes Paid
IncomeTaxesPaid
41000
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Interest Paid Net
InterestPaidNet
1178000
us-gaap Interest Paid Net
InterestPaidNet
1934000
tkno Debt Issuance Costs Included In Accrued Liabilities
DebtIssuanceCostsIncludedInAccruedLiabilities
0
tkno Debt Issuance Costs Included In Accrued Liabilities
DebtIssuanceCostsIncludedInAccruedLiabilities
23000
tkno Offering Costs Included In Accounts Payable And Accrued Liabilities
OfferingCostsIncludedInAccountsPayableAndAccruedLiabilities
18000
tkno Offering Costs Included In Accounts Payable And Accrued Liabilities
OfferingCostsIncludedInAccountsPayableAndAccruedLiabilities
353000
tkno Capitalized Property Plant And Equipment Included In Accounts Payable And Accrued Liabilities
CapitalizedPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities
90000
tkno Capitalized Property Plant And Equipment Included In Accounts Payable And Accrued Liabilities
CapitalizedPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities
205000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
132000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
0
tkno Recognition Of Operating Right Of Use Lease Asset
RecognitionOfOperatingRightOfUseLeaseAsset
1293000
tkno Recognition Of Operating Right Of Use Lease Asset
RecognitionOfOperatingRightOfUseLeaseAsset
-1137000
tkno Recognition Of Operating Lease Liabilities
RecognitionOfOperatingLeaseLiabilities
1306000
tkno Recognition Of Operating Lease Liabilities
RecognitionOfOperatingLeaseLiabilities
-1193000
us-gaap Nature Of Operations
NatureOfOperations
<p id="i_notes" style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 1. Nature of th</span><span style="color:#231f20;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">e Business</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Teknova produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Our product offerings include pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. Teknova supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions, with catalog and custom, made-to-order products.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Teknova manufactures its products at its Hollister, California, headquarters and stocks inventory of raw materials, components, and finished goods at that location. The Company ships products directly from its warehouse in Hollister to its customers and distributors.</span></p>
tkno Warrants Policy Policytextblock
WarrantsPolicyPolicytextblock
<p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Warrants</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 480, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Distinguishing Liabilities from Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> (ASC 480) and ASC 815, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Derivatives and Hedging </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(ASC 815). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.</span></p>
tkno Short Term Held To Maturity Investmentspolicypolicytextblock
ShortTermHeldToMaturityInvestmentspolicypolicytextblock
<p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Short-term Held-to-Maturity Investments</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company invests excess cash balances in short-term U.S. Treasuries. Investments are classified based on the facts and circumstances present at the time of purchase. The appropriateness of that classification is subsequently reassessed at each reporting date. As of September 30, 2024, the Company has both the ability and intention to hold these investments until maturity and therefore has classified these investments as held-to-maturity and recorded them at amortized cost which approximates fair value and presented them in “Short-term investments, held -to-maturity” on the balance sheet. The fair value of the Company's short-term investments was based on quoted prices in active markets for these investments </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Level 1). The income recognized for these investments is recorded within interest income on the statement of operations.</span></p>
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9576000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8169000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28480000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28817000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9576000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8169000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28480000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28817000
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5235000
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8573000
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
134000
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
47000
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
2305000
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2974000
CY2024Q3 us-gaap Inventory Net
InventoryNet
7674000
CY2023Q4 us-gaap Inventory Net
InventoryNet
11594000
CY2024Q3 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
55862000
CY2023Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
55888000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11439000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7528000
CY2024Q3 tkno Property Plant And Equipment After Depreciation
PropertyPlantAndEquipmentAfterDepreciation
44423000
CY2023Q4 tkno Property Plant And Equipment After Depreciation
PropertyPlantAndEquipmentAfterDepreciation
48360000
CY2024Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
2292000
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
2004000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46715000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50364000
CY2024Q3 us-gaap Depreciation
Depreciation
1400000
us-gaap Depreciation
Depreciation
4100000
CY2023Q3 us-gaap Depreciation
Depreciation
1300000
us-gaap Depreciation
Depreciation
3200000
CY2024Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
900000
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
745000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
640000
us-gaap Operating Lease Cost
OperatingLeaseCost
2236000
us-gaap Operating Lease Cost
OperatingLeaseCost
2041000
CY2024Q3 us-gaap Variable Lease Cost
VariableLeaseCost
109000
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
54000
us-gaap Variable Lease Cost
VariableLeaseCost
326000
us-gaap Variable Lease Cost
VariableLeaseCost
164000
CY2024Q3 us-gaap Lease Cost
LeaseCost
854000
CY2023Q3 us-gaap Lease Cost
LeaseCost
694000
us-gaap Lease Cost
LeaseCost
2562000
us-gaap Lease Cost
LeaseCost
2205000
CY2024Q3 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
700000
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
2100000
CY2023Q3 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
600000
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
2100000
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.05
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y2M12D
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
703000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2569000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2627000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2631000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2480000
CY2024Q3 tkno Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
10296000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
21306000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4105000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
17201000
CY2024Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
19930000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6552000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13378000
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
19930000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5691000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14239000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
900000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
900000
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P2Y3M18D
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
287000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1148000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1148000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
45000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2628000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2712000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3826000
CY2024Q3 tkno Accrued Liabilities Property Plant And Equipment Current
AccruedLiabilitiesPropertyPlantAndEquipmentCurrent
90000
CY2023Q4 tkno Accrued Liabilities Property Plant And Equipment Current
AccruedLiabilitiesPropertyPlantAndEquipmentCurrent
0
CY2024Q3 us-gaap Deferred Revenue
DeferredRevenue
34000
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
16000
CY2024Q3 tkno Insurance Premiums And Accrued Interest
InsurancePremiumsAndAccruedInterest
222000
CY2023Q4 tkno Insurance Premiums And Accrued Interest
InsurancePremiumsAndAccruedInterest
409000
CY2024Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
373000
CY2023Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
300000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
942000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1028000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4373000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5579000
CY2024Q3 tkno Terms Of Financing Agreement Premium Amount
TermsOfFinancingAgreementPremiumAmount
600000
CY2024Q3 tkno Annual Interest Rate To Finance For Insurance Premiums
AnnualInterestRateToFinanceForInsurancePremiums
0.0849
CY2024Q3 tkno Insurance Premiums Down Payment
InsurancePremiumsDownPayment
200000
CY2024Q3 tkno Aggregate Amount Of Monthly Installments Paid
AggregateAmountOfMonthlyInstallmentsPaid
200000
CY2024Q3 tkno Insurance Premiums And Accrued Interest
InsurancePremiumsAndAccruedInterest
200000
CY2024Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
5000000
CY2024Q1 us-gaap Line Of Credit Facility Description
LineOfCreditFacilityDescription
If any advance under the Term Loan is prepaid at any time, a prepayment fee is charged based on the amount being prepaid and an applicable percentage amount, such as 4%, 3%, or 1%, based on the date the prepayment is made
CY2024Q1 us-gaap Debt Instrument Covenant Description
DebtInstrumentCovenantDescription
No. 5 also removed those requirements for the periods ending January 31, 2025 through December 31, 2025, instead requiring that for each applicable twelve-month period ending after December 31, 2024, the Company’s minimum net revenue requirement will be determined by MidCap in its reasonable discretion in consultation with the Company’s senior management and based on financial statements and projections delivered to MidCap in accordance with the financial reporting requirements in the Amended Credit Agreement, so long as the minimum net revenue requirements for those periods shall not be less than the greater of (x) the applicable minimum net revenue requirement for the twelve-month period ending on the last day of the immediately preceding month and (y) $34.0 million
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
100000
CY2024Q1 tkno Term Loan Exit Fee Percent
TermLoanExitFeePercent
0.09
CY2024Q3 tkno Term Loan
TermLoan
12135000
CY2023Q4 tkno Term Loan
TermLoan
12135000
CY2024Q3 tkno Debt Instrument Cumulative Accretion Of Exit Fee
DebtInstrumentCumulativeAccretionOfExitFee
1472000
CY2023Q4 tkno Debt Instrument Cumulative Accretion Of Exit Fee
DebtInstrumentCumulativeAccretionOfExitFee
1261000
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
222000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
145000
CY2024Q3 tkno Total Debt Amount
TotalDebtAmount
13385000
CY2023Q4 tkno Total Debt Amount
TotalDebtAmount
13251000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2528000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
10857000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
13251000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3539000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
6068000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2528000
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
12135000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.3605
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.3543
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.3591
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.3508
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0349
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0454
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0433
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0415
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y11M12D
CY2024Q3 tkno Weighted Average Fair Value Of Common Stock
WeightedAverageFairValueOfCommonStock
4.4
CY2023Q3 tkno Weighted Average Fair Value Of Common Stock
WeightedAverageFairValueOfCommonStock
1.95
tkno Weighted Average Fair Value Of Common Stock
WeightedAverageFairValueOfCommonStock
2.86
tkno Weighted Average Fair Value Of Common Stock
WeightedAverageFairValueOfCommonStock
5.05
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.84
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.57
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.24
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.12
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
760000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1035000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2900000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3115000
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.002
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-7565000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10153000
us-gaap Net Income Loss
NetIncomeLoss
-21026000
us-gaap Net Income Loss
NetIncomeLoss
-26124000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51821395
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51821395
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29956930
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29956930
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44520132
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44520132
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28810068

Files In Submission

Name View Source Status
0000950170-24-124159-index-headers.html Edgar Link pending
0000950170-24-124159-index.html Edgar Link pending
0000950170-24-124159.txt Edgar Link pending
0000950170-24-124159-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tkno-20240930.htm Edgar Link pending
tkno-20240930.xsd Edgar Link pending
tkno-ex31_1.htm Edgar Link pending
tkno-ex31_2.htm Edgar Link pending
tkno-ex32_1.htm Edgar Link pending
tkno-20240930_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable